Abstract

Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States

Highlights

  • To the Editor: In the United States, almost 80% of tuberculosis (TB) cases are diagnosed on the basis of positive culture results for Mycobacterium tuberculosis, and >90% of initial isolates are tested for drug susceptibilities [1,2]

  • The remaining 386 (3.8%) cases were excluded from analysis because the patients had pyrazinamide-monoresistant TB, suggestive of Mycobacterium bovis infection [165], or they were missing susceptibility testing results for isoniazid, rifampin, or ethambutol [112] or had other resistance patterns [109]

  • Cases were among patients who were alive and initiated therapy at diagnosis and who had start and end therapy dates as well as results for initial drug susceptibility testing to isoniazid, rifampin, and ethambutol

Read more

Summary

Introduction

To the Editor: In the United States, almost 80% of tuberculosis (TB) cases are diagnosed on the basis of positive culture results for Mycobacterium tuberculosis, and >90% of initial isolates are tested for drug susceptibilities [1,2]. We calculated treatment duration for patients who were alive and had initiated TB therapy at diagnosis and who had results for initial drug susceptibility testing. Of the 10,747 patients with culture-confirmed TB, 10,120 (94.2%) were alive and had initiated TB therapy at diagnosis and had start and end therapy dates and initial drug susceptibility results.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.